Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study observed increased online searches for "acne," "eczema," and "hair loss" but decreased interest in "botox," "skin cancer," and some other terms during the COVID-19 pandemic in Turkey and Italy.

This study analyzed Google Trends data to explore public interest in various alopecia-related terms from 2018 to 2023, finding that search volumes for "androgenetic alopecia" and "frontal fibrosing alopecia" increased, while other terms remained stable, with notable geographic variations in search interest.

This study analyzed Google Trends data from 2018 to 2023, revealing an increasing global interest in hair loss treatments, particularly for "oral minoxidil" and "dutasteride," though interest varies by region and treatment type.

This study found significant seasonal variations in public interest for several skin conditions, including tinea pedis, pruritus, and psoriasis, among others, based on Google search trends in Türkiye from January 2022 to January 2025.

Public interest in COVID-19-related hair loss increased during COVID-19 surges, especially with the omicron variant.

Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.

This study observed that public interest in JAK-inhibitor treatments for alopecia areata significantly increased around the FDA approval in 2022 and heightened media coverage, suggesting an important role for patient education about these treatments.

This article highlights the rising interest in Janus kinase inhibitors for alopecia areata, especially following the FDA approval of baricitinib, underscoring the need for better patient education and physician guidance in selecting appropriate treatments for hair loss.

This study found that there was a significant increase in Google searches for "oral minoxidil" following a New York Times article, suggesting heightened public interest in this treatment for androgenetic alopecia.

This study reported a significant increase in global online searches for finasteride and its possible sexual side effects, particularly after the FDA's 2012 warning.

Hair loss is more common in summer and fall.

This study assessed the impact of a New York Times article on consumer interest in androgenetic alopecia treatments by surveying dermatologists about practice trends and analyzing online search data related to low dose oral minoxidil and hair loss from February 2022 to February 2023.

This study reported that during the COVID-19 pandemic, online searches for general dermatologic conditions returned to prepandemic levels, while interest in premalignant, cancerous conditions, and cosmetic procedures remained low.

This study analyzed online patient reviews for abdominoplasty and found significant themes affecting satisfaction, highlighting that higher ratings were strongly associated with positive aesthetic outcomes, staff interactions, and postoperative care.

This study analyzed online information about PCOS and found that while the accuracy of the information was generally high, the readability was poor, suggesting a need for more accessible resources for patients.

This study found that the increasing visits to online prescription platforms for MQ-based finasteride treatment in androgenetic alopecia suggest a significant shift in medical care towards digital health services.

This study found that most adverse events reported for HPV vaccines in the VAERS system were non-serious and already known, although less common events suggest the need for further examination.

This study found that Facebook hair loss treatment content is primarily advertisement-driven and seldom supported by medical evidence, with user engagement being generally low for evidence-based posts.

This study found that patients using GLP-1 receptor agonists, specifically liraglutide, dulaglutide, and semaglutide, had a higher likelihood of being diagnosed with androgenetic alopecia, while those on exenatide showed increased odds for both androgenetic alopecia and telogen effluvium.

Online tools are effective and cost-efficient for recruiting dermatology research participants, especially among younger people.

In this study, researchers found that nearly half of Korean women with female pattern hair loss showed temporal scalp involvement, with a decrease in temporal hair density compared to occipital areas.

This study conducted an integrative review of bioactive substances and their effectiveness in controlling hair loss and scalp disorders, evaluating their potential to restore hair cycle balance and strengthen hair strands, while identifying knowledge gaps and opportunities for future research.

This study found that androgen receptors were more highly expressed in bald scalp areas compared to non-bald areas, suggesting a link between local androgen activity and hair loss in androgenic alopecia.

This study found that gene expression changes in hair bulb cells are linked to graying hair, affecting processes like melanogenesis and cell-cell interaction.

This study suggests that morphometric analysis using horizontal sectioning of scalp biopsies is effective for diagnosing alopecia in Koreans, but follicular count differences from Caucasians should be considered.

Media coverage increased public interest in oral minoxidil for hair loss but may also spread misinformation.

This review assesses whether using letrozole alongside physical activity and nutrition is clinically beneficial for enhancing ovulation outcomes in women with PCOS-related infertility, but it doesn't report specific results from the evaluation.

This study reported that oral JAK inhibitors, tofacitinib and ruxolitinib, may effectively promote hair regrowth in alopecia areata patients, though ruxolitinib had fewer adverse events compared to tofacitinib.